Literature DB >> 32934346

Quercetin prevents bone loss in hindlimb suspension mice via stanniocalcin 1-mediated inhibition of osteoclastogenesis.

Yin-Bo Niu1, Yuan-Yuan Yang1, Xuan Xiao1,2, Yang Sun3, Yu-Mei Zhou3, Yu-Han Zhang1, Dong Dong1, Chen-Rui Li1, Xiang-Long Wu1, Yu-Hua Li4, Qi-Bing Mei5,6.   

Abstract

Recent studies demonstrate that diet quercetin (Quer) has obvious bone protective effects on ovariectomized rodents but thus far there is no direct evidence to support the inhibitory effect of Quer on bone loss caused by long-term unloading. In the present study, we investigated whether Quer could prevent bone loss induced by unloading in mice. Mice were subjected to hindlimb suspension (HLS) and received Quer (25, 50, 100 mg· kg-1 ·day-1, ig) for 4 weeks. Before euthanasia blood sample was collected; the femurs were harvested and subjected to MicroCT analysis. We showed that Quer administration markedly improved bone microstructure evidenced by dose-dependently reversing the reduction in bone volume per tissue volume, trabecular number, and bone mineral density, and the increase of trabecular spacing in mice with HLS. Analysis of serum markers and bone histometric parameters confirmed that Quer at both middle and high doses significantly decreased bone resorption-related markers collagen type I and tartrate-resistant acid phosphatase 5b, and increased bone formation-related marker procollagen 1 N-terminal propeptide as compared with HLS group. Treatment with Quer (1, 2, 5 μM) dose-dependently inhibited RANKL-induced osteoclastogenesis through promoting the expression of antioxidant hormone stanniocalcin 1 (STC1) and decreasing ROS generation; knockdown of STC1 blocked the inhibitory effect of Quer on ROS generation. Knockdown of STC1 also significantly promoted osteoclastogenesis in primary osteoclasts. In conclusion, Quer protects bones and prevents unloading-caused bone loss in mice through STC1-mediated inhibition of osteoclastogenesis. The findings suggest that Quer has the potential to prevent and treat off-load bone loss as an alternative supplement.

Entities:  

Keywords:  ROS; STC1; bone loss; hindlimb suspension mice; osteoclast; quercetin

Year:  2020        PMID: 32934346      PMCID: PMC7656592          DOI: 10.1038/s41401-020-00509-z

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  5 in total

1.  Investigation of the effects of eugenol and quercetin on bone loss in STZ-NA induced diabetic rats utilizing micro CT.

Authors:  Aycan Baş; Işıl Albeniz
Journal:  J Diabetes Metab Disord       Date:  2022-03-12

2.  A mouse model of disuse osteoporosis based on a movable noninvasive 3D-printed unloading device.

Authors:  Junhui Li; Jiangyu Geng; Tingting Lin; Mingxiang Cai; Yao Sun
Journal:  J Orthop Translat       Date:  2022-01-06       Impact factor: 5.191

Review 3.  Roles of Altered Macrophages and Cytokines: Implications for Pathological Mechanisms of Postmenopausal Osteoporosis, Rheumatoid Arthritis, and Alzheimer's Disease.

Authors:  Yunteng Xu; Hui Yan; Xin Zhang; Junkuan Zhuo; Yidan Han; Haifeng Zhang; Dingbang Xie; Xin Lan; Wanping Cai; Xiaoning Wang; Shanshan Wang; Xihai Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-10       Impact factor: 6.055

4.  Effect of Quercetin 3-O-β-D-Galactopyranoside on the Adipogenic and Osteoblastogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stromal Cells.

Authors:  Jung Hwan Oh; Fatih Karadeniz; Youngwan Seo; Chang-Suk Kong
Journal:  Int J Mol Sci       Date:  2020-10-28       Impact factor: 5.923

Review 5.  The Role of Macronutrients, Micronutrients and Flavonoid Polyphenols in the Prevention and Treatment of Osteoporosis.

Authors:  Monika Martiniakova; Martina Babikova; Vladimira Mondockova; Jana Blahova; Veronika Kovacova; Radoslav Omelka
Journal:  Nutrients       Date:  2022-01-25       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.